Here's Won't Touch Teva: Why I Pass on the Generic Giant
Teva Pharmaceuticals sits at a crossroads of debt, generics, and a shifting pricing landscape. Here's why I won't tou...
Understand how tax efficiency varies among total market funds, and what factors influence after-tax returns for retirement investing.
28,571 articlesTeva Pharmaceuticals sits at a crossroads of debt, generics, and a shifting pricing landscape. Here's why I won't tou...
Radian Group confirms it will wind down its mortgage conduit business following a divestiture review, while continuin...
Silver trades near $68 per ounce as a hawkish Federal Reserve keeps the dollar firm. The market faces a critical test...
With a high-stakes Xi meeting on the horizon, President Trump has launched a calculated charm offensive, attracting t...
Companies are ditching token-based performance dashboards as ROI from AI pivots to concrete business outcomes like re...
New CPI data renews tensions between Trump’s White House and Fed Chair Warsh, signaling a potential policy clash as i...
HUD launches two tech-enabled pilots designed to increase housing supply and cut costs. The programs target robotics ...
Venice AI has secured $65 million in a Series A round led by Dragonfly, valuing the company at $1 billion as it expan...
A growing share of CFOs now oversee strategic planning, signaling a shift in how companies allocate capital and pursu...
Unum Group operates in the steady world of employer benefits and personal protection. If three key trends line up—und...
The U.S. and Israel launched airstrikes on Iran after weeks of buildup, triggering immediate market volatility. Oil, ...
A sudden move lower in AeroVironment stock has traders and long-term holders asking what happened. This guide breaks ...